The Impact of Skin Problems on the Quality of Life in Patients Treated with Anticancer Agents: A Cross-Sectional Study

키워드

참고문헌 (33)

1. Byun HJ, "Daily skin care habits and the risk of skin eruptions and symptoms in cancer patients", Ann Oncol, 23, pp.1992~1998 (2012)
2. Boone SL, "Impact and management of skin toxicity associated with anti-epidermal growth factor receptor therapy: survey results", Oncology, 72, pp.152~159 (2007)
3. Lacouture ME, "The growing importance of skin toxicity in EGFR inhibitor therapy", Oncology (Williston Park), 23, pp.194~ (2009)
4. Huang V, "Dermatologic manifestations of cytotoxic therapy", Dermatol Ther, 24, pp.401~410 (2011)
5. Jatoi A, "Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebocontrolled trial from the North Central Cancer Treatment Group (N03CB)", Cancer, 113, pp.847~853 (2008)
6. Garden BC, "The risk of nail changes with epidermal growth factor receptor inhibitors: a systematic review of the literature and meta-analysis", J Am Acad Dermatol, 67, pp.400~408 (2012)
7. Balagula Y, "Dermatologic toxicities of targeted anticancer therapies", J Support Oncol, 8, pp.149~161 (2010)
8. Robert C, "Cutaneous side-effects of kinase inhibitors and blocking antibodies", Lancet Oncol, 6, pp.491~500 (2005)
9. Osio A, "Cutaneous side-effects in patients on long-term treatment with epidermal growth factor receptor inhibitors", Br J Dermatol, 161, pp.515~521 (2009)
10. Nardone B, "The effect of hand-foot skin reaction associated with the multikinase inhibitors sorafenib and sunitinib on health-related quality of life", J Drugs Dermatol, 11, pp.61~65 (2012)
11. Sibaud V, "HFS-14, a specific quality of life scale developed for patients suffering from hand-foot syndrome", Oncologist, 16, pp.1469~1478 (2011)
12. Unger K, "Treatment of metastatic colorectal cancer with cetuximab: influence on the quality of life", Z Gastroenterol, 51, pp.733~739 (2013)
13. Chan A, "A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies", Support Care Cancer, 23, pp.2231~2244 (2015)
14. Rosen AC, "Impact of dermatologic adverse events on quality of life in 283 cancer patients: a questionnaire study in a dermatology referral clinic", Am J Clin Dermatol, 14, pp.327~333 (2013)
15. Charles C, "Impact of dermatologic adverse events induced by targeted therapies on quality of life", Crit Rev Oncol Hematol, 101, pp.158~168 (2016)
16. Basch E, "Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study", Lancet Oncol, 7, pp.903~909 (2006)
17. Finlay AY, "Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use", Clin Exp Dermatol, 19, pp.210~216 (1994)
18. Lewis V, "10 years experience of the Dermatology Life Quality Index (DLQI)", J Investig Dermatol Symp Proc, 9, pp.169~180 (2004)
19. Finlay AY, "Dermatology life quality index (DLQI): a paradigm shift to patient-centered outcomes", J Invest Dermatol, 132, pp.2464~2465 (2012)
20. Basra MK, "Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data", Dermatology, 230, pp.27~33 (2015)
21. Sampogna F, "Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis", Br J Dermatol, 154, pp.325~331 (2006)
22. Shah M, "An assessment of the quality of life in older patients with skin disease", Br J Dermatol, 154, pp.150~153 (2006)
23. Nakao M, "Effects of gender and marital status on somatic symptoms of patients attending a mind", body medicine clinic, 2001, pp.26, 159~168
24. Macintyre S, "Do women 'over-report' morbidity? Men's and women's responses to structured prompting on a standard question on long standing illness", Soc Sci Med, 48, pp.89~98 (1999)
25. Holm EA, "Does visible atopic dermatitis affect quality of life more in women than in men?", Gend Med, 1, pp.125~130 (2004)
26. Gilbar P, "Nail toxicity induced by cancer chemotherapy", J Oncol Pharm Pract, 15, pp.143~155 (2009)
27. Minisini AM, "Taxane-induced nail changes: incidence, clinical presentation and outcome", Ann Oncol, 14, pp.333~337 (2003)
28. Joshi SS, "Effects of epidermal growth factor receptor inhibitor-induced dermatologic toxicities on quality of life", Cancer, 116, pp.3916~3923 (2010)
29. Gupta MA, "Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis", Br J Dermatol, 139, pp.846~850 (1998)
30. Cash TF, "The psychological effects of androgenetic alopecia in men", J Am Acad Dermatol, 26, pp.926~931 (1992)
31. Cash TF, "The psychology of hair loss and its implications for patient care", Clin Dermatol, 19, pp.161~166 (2001)
32. Ljosaa TM, "Skin pain and skin discomfort is associated with quality of life in patients with psoriasis", J Eur Acad Dermatol Venereol, 26, pp.29~35 (2012)
33. Mendez-Flores S, "Pain and pruritus in cutaneous lupus: their association with dermatologic quality of life and disease activity", Clin Exp Rheumatol, 31, pp.940~942 (2013)

관련 논문AI추천